摘要
考虑到大脑和周边组织的病理生理学变化,阿尔茨海默病作为一种系统病理学疾病的出现改变了研究规范以便更好的了解该疾病的分子基础。在目前研究中,我们评估了病程进展对3、6和12个月龄的三转基因老年痴呆小鼠模型及相对应年龄的非转基因小鼠的骨骼肌生理相关特征的影响。我们的结果表明3个月龄的3xTg-AD小鼠的骨骼肌功能已经受到影响,由乙酰胆碱酯酶和过氧化氢酶活性的缺乏及线粒体膜脂肪酸组分的变化得到证明。此外,3xTg-AD小鼠骨骼肌中的β1-40 淀粉样蛋白随着年龄增长积累增加,这种影响发生于线粒体生物学功能障碍之前,并且仅12月龄小鼠出现这种状况,以呼吸控制率和ADP/O 指数减少及复合酶体I活性降低为特征。与年龄相一致的非转基因小鼠相比,HPLC-MS/MS 分析法表明12月龄的3xTg-AD小鼠骨骼肌中的磷脂组分发生了明显变化。在3xTg-AD小鼠中发现溶血卵磷脂水平的增加与含有花生四烯酸卵磷脂的分子种类减少相关,显示磷脂酶A2活性及骨骼肌炎症增强。另外与年龄相一致的非转基因小鼠相比,观察到3xTg-AD小鼠中缩醛磷脂酰乙醇胺含量减少及磷脂酰肌醇水平的增加。总之,这些观察数据提示3xTg-AD 小鼠骨骼肌更易于发生氧化及炎症反应。
关键词: 阿尔茨海默病,β淀粉样,脂类组学,线粒体生物学功能,磷脂酶A2,磷脂质,骨骼肌
Current Alzheimer Research
Title:Age-Dependent Biochemical Dysfunction in Skeletal Muscle of Triple- Transgenic Mouse Model of Alzheimer`s Disease
Volume: 12 Issue: 2
Author(s): Vera F. Monteiro-Cardoso, Marisa Castro, M.M. Oliveira, Paula I. Moreira, Francisco Peixoto and Romeu A. Videira
Affiliation:
关键词: 阿尔茨海默病,β淀粉样,脂类组学,线粒体生物学功能,磷脂酶A2,磷脂质,骨骼肌
摘要: The emergence of Alzheimer`s disease as a systemic pathology shifted the research paradigm toward a better understanding of the molecular basis of the disease considering the pathophysiological changes in both brain and peripheral tissues. In the present study, we evaluated the impact of disease progression on physiological relevant features of skeletal muscle obtained from 3, 6 and 12 month-old 3xTg-AD mice, a model of Alzheimer`s disease, and respective agematched nonTg mice. Our results showed that skeletal muscle functionality is already affected in 3-month-old 3xTg-AD mice as evidenced by deficient acetylcholinesterase and catalase activities as well as by alterations in fatty acid composition of mitochondrial membranes. Additionally, an age-dependent accumulation of amyloid-β1-40 peptide occurred in skeletal muscle of 3xTg-AD mice, an effect that preceded bioenergetics mitochondrial dysfunction, which was only detected at 12 months of age, characterized by decreased respiratory control ratio and ADP/O index and by an impairment of complex I activity. HPLC-MS/MS analyses revealed significant changes in phospholipid composition of skeletal muscle tissues from 3xTg-AD mice with 12 months of age when compared with age-matched nonTg mice. Increased levels of lyso-phosphatidylcholine associated with a decrease of phosphatidylcholine molecular species containing arachidonic acid were detected in 3xTg-AD mice, indicating an enhancement of phospholipase A2 activity and skeletal muscle inflammation. Additionally, a decrease of phosphatidylethanolamine plasmalogens content and an increase in phosphatidylinositol levels was observed in 3xTg-AD mice when compared with age-matched nonTg mice. Altogether, these observations suggest that the skeletal muscle of 3xTg-AD mice are more prone to oxidative and inflammatory events.
Export Options
About this article
Cite this article as:
Vera F. Monteiro-Cardoso, Marisa Castro, M.M. Oliveira, Paula I. Moreira, Francisco Peixoto and Romeu A. Videira , Age-Dependent Biochemical Dysfunction in Skeletal Muscle of Triple- Transgenic Mouse Model of Alzheimer`s Disease, Current Alzheimer Research 2015; 12 (2) . https://dx.doi.org/10.2174/1567205012666150204124852
DOI https://dx.doi.org/10.2174/1567205012666150204124852 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook
Current Pharmaceutical Design Prevalence and Predictors of Overweight and Obesity in Patients with Pituitary Dysfunctions
Endocrine, Metabolic & Immune Disorders - Drug Targets Polymeric Nanocarriers and Nanoreactors: A Survey of Possible Therapeutic Applications
Current Pharmaceutical Design Antidepressants: Update on Benefits and Risks
Current Psychopharmacology Pharmacological Countermeasures for the Acute Radiation Syndrome
Current Molecular Pharmacology Atherosclerosis as an Inflammatory Disease
Current Pharmaceutical Design Energy Expenditure of Hunter-Gatherers: When Statistics Turns to be Unreliable
Endocrine, Metabolic & Immune Disorders - Drug Targets Mechanisms Involved in BACE Upregulation Associated to Stress
Current Alzheimer Research Serotonin Receptors of Type 6 (5-HT6): What can we Expect from them?
Current Medicinal Chemistry Small Peptide and Protein-based Molecular Probes for Imaging Neurological Diseases
Current Protein & Peptide Science Glucocorticoids and the Cardiovascular System: State of the Art
Current Pharmaceutical Design Screening for Rare Genetic Variants Associated with Atherosclerosis: Opportunity for Personalized Medicine
Current Vascular Pharmacology TREM2 p.H157Y Variant and the Risk of Alzheimer’s Disease: A Meta-Analysis Involving 14,510 Subjects
Current Neurovascular Research Stroke Prevention in Patients with Non-valvular Atrial Fibrillation: New Insight in Selection of Rhythm or Rate Control Therapy and Impact of Mean Platelet Volume
Current Pharmaceutical Design Central Insulin and Insulin-Like Growth Factor-1 Signaling - Implications for Diabetes Associated Dementia
Current Diabetes Reviews Tumor Necrosis Factor Blocking Therapy and Congestive Heart Failure in Patients with Inflammatory Rheumatic Disorders: A Systematic Review
Current Medicinal Chemistry Neural and Behavioral Responses to Systemic Immunologic Stimuli: A Consideration of Bacterial T Cell Superantigens
Current Pharmaceutical Design Analysis of Functional Brain Images Using Population-Based Probabilistic Atlas
Current Medical Imaging Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review
Current Topics in Medicinal Chemistry Evolution of Antipsychotic Intervention in the Schizophrenic Psychosis
Current Drug Targets